Clinical Trial Update: Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions [Phase 1]

View source ↗

Summary

Phase 1 relative bioavailability study comparing a Bicalutamide 50 mg tablet (Sandoz) with Casodex under fed conditions in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hirsutism
• Prostate Cancer

Drugs mentioned

• Bicalutamide 50 mg Tablet (bicalutamide)
• Casodex (bicalutamide)

Snippet

Sponsor: Sandoz | Conditions: Prostate Cancer, Hirsutism | Phase 1 | Status: COMPLETED